Neutral buoyancy and sleep-deprived serum factors alter expression of cytokines regulating osteogenesis

被引:4
作者
Gorczynski, RM [1 ]
Gorezynski, CP [1 ]
Gorczynski, LY [1 ]
Hu, J [1 ]
Lu, J [1 ]
Manuel, J [1 ]
Lee, L [1 ]
机构
[1] Univ Hlth Network, Toronto Gen Hosp, Transplant Res Div, Toronto, ON M5G 2C4, Canada
关键词
D O I
10.1016/j.actaastro.2005.01.015
中图分类号
V [航空、航天];
学科分类号
08 ; 0825 ;
摘要
We examined expression of genes associated with cytokine production, and genes implicated in regulating bone metabolism, in bone stromal and osteoblast cells incubated under standard ground conditions and under conditions of neutral buoyancy, and in the presence/absence of serum from normal or sleep-deprived mice. We observed a clear interaction between these two conditions (exposure to neutral buoyancy and serum stimulation) in promoting enhanced osteoclastogenesis. Both conditions independently altered expression of a number of cytokines implicated in the regulation of bone metabolism. However, using stromal cells from IL-1 and TNFα cytokine(r) KO mice, we concluded that the increased bone loss under microgravity conditions was not primarily cytokine mediated. © 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:890 / 899
页数:10
相关论文
共 17 条
  • [11] Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand
    Kong, YY
    Feïge, U
    Sarosi, I
    Bolon, B
    Tafuri, A
    Morony, S
    Capparelli, C
    Li, J
    Elliott, R
    McCabe, S
    Wong, T
    Campagnuolo, G
    Moran, E
    Bogoch, ER
    Van, G
    Nguyen, LT
    Ohashi, PS
    Lacey, DL
    Fish, E
    Boyle, WJ
    Penninger, JM
    [J]. NATURE, 1999, 402 (6759) : 304 - 309
  • [12] OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis
    Kong, YY
    Yoshida, H
    Sarosi, I
    Tan, HL
    Timms, E
    Capparelli, C
    Morony, S
    Oliveira-dos-Santos, AJ
    Van, G
    Itie, A
    Khoo, W
    Wakeham, A
    Dunstan, CR
    Lacey, DL
    Mak, TW
    Boyle, WJ
    Penninger, JM
    [J]. NATURE, 1999, 397 (6717) : 315 - 323
  • [13] Osteoprotegerin: A physiological and pharmacological inhibitor of bone resorption
    Kostenuik, PJ
    Shalhoub, V
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2001, 7 (08) : 613 - 635
  • [14] Opposite effects of bone morphogenetic protein-2 and transforming growth factor-β1 on osteoblast differentiation
    Spinella-Jaegle, S
    Roman-Roman, S
    Faucheu, C
    Dunn, FW
    Kawai, S
    Galléa, S
    Stiot, V
    Blanchet, AM
    Courtois, B
    Baron, R
    Rawadi, G
    [J]. BONE, 2001, 29 (04) : 323 - 330
  • [15] Stimulation of osteoprotegerin (OPG) gene expression by transforming growth factor-β (TGF-β) -: Mapping of the OPG promoter region that mediates TGF-β effects
    Thirunavukkarasu, K
    Miles, RR
    Halladay, DL
    Yang, XH
    Galvin, RJS
    Chandrasekhar, S
    Martin, TJ
    Onyia, JE
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (39) : 36241 - 36250
  • [16] Double mutations in klotho and osteoprotegerin gene loci rescued osteopetrotic phenotype
    Yamashita, T
    Okada, S
    Higashio, K
    Nabeshima, YI
    Noda, M
    [J]. ENDOCRINOLOGY, 2002, 143 (12) : 4711 - 4717
  • [17] A novel osteoblast-derived C-type lectin that inhibits osteoclast formation
    Zhou, H
    Kartsogiannis, V
    Hu, YS
    Elliott, J
    Quinn, JMW
    McKinstry, WJ
    Gillespie, MT
    Ng, KW
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (18) : 14916 - 14923